Sahatanand Biotech Inc Gaithersburg, MD - 20878

Sahatanand Biotech Inc is categorized under Commercial Biotechnical Research in Gaithersburg, MD and active since 2005.

Sahatanand Biotech Inc was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Dhirajlal Kotadia at the company’s single location by writing to 20 Firstfield Road # 190, Gaithersburg, Maryland MD 20878 or by phoning (240) 268-1201. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Sahatanand Biotech Inc
Contact Person: Dhirajlal Kotadia
Address: 20 Firstfield Road # 190, Gaithersburg, Maryland 20878
Phone Number: (240) 268-1201
Annual Revenue (USD): $100.000 to $499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Sahatanand Biotech Inc was started in 2005 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Dhirajlal Kotadia for inquiries that concern Sahatanand Biotech Inc by calling the company number (240) 268-1201, as your correspondence is most welcome. Additionally, the physical location of the single location of Sahatanand Biotech Inc can be found at the coordinates 39.139772,-77.22448 as well as the street address 20 Firstfield Road # 190 in Gaithersburg, Maryland 20878.

For its online presence, you may visit Sahatanand Biotech Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.